Year |
Citation |
Score |
2017 |
Rada M, Eldred C, Sage J, Orsulic S, Cheon D. Abstract TMEM-017: COLLAGEN TYPE XI ALPHA 1 (COL11A1) IS A NOVEL STROMAL MEDIATOR OF CHEMORESISTANCE Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Tmem-017 |
0.768 |
|
2017 |
Rada M, Cha J, Sage J, Orsulic S, Cheon D. Abstract 2975: Collagen type XI alpha 1 confers cisplatin chemoresistance in ovarian cancer through inhibitor of apoptosis proteins (IAPs) Cancer Research. 77: 2975-2975. DOI: 10.1158/1538-7445.Am2017-2975 |
0.724 |
|
2015 |
Beach JA, Aspuria P, Cheon D, Gozo MC, Karlan BY, Orsulic S. Abstract B09: Sphingosine kinase 1 (SPHK1) is a novel mediator of tumor-stroma interaction in ovarian cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B09 |
0.728 |
|
2015 |
Cheon D, Beach J, Walts A, Karlan B, Orsulic S. Abstract A39: COL11A1 is a regulator of tumor microenvironment and a biomarker of metastatic progression Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-A39 |
0.738 |
|
2014 |
Taylor-Harding B, Agadjanian H, Aspuria P, Cheon D, Mizuno T, Greenberg D, Allen JR, Orsulic S, Walsh C, Karlan BY, Wiedemeyer WR. Abstract 678: The Ets factor ETV5 regulates E2F target genes and mediates drug resistance Cancer Research. 74: 678-678. DOI: 10.1158/1538-7445.Am2014-678 |
0.693 |
|
2014 |
Li A, Cheon D, Karlan B, Orsulic S. The prognostic significance of ADAM metallopeptidase domain 12 in advanced stage serous ovarian cancer Gynecologic Oncology. 135: 386. DOI: 10.1016/J.Ygyno.2014.07.018 |
0.64 |
|
2013 |
Agadjanian H, Cheon D, Diaz E, Laury A, Miller C, Karlan B, Orsulic S, Walsh C. Abstract 329: A mouse model of epithelial ovarian cancer with defined oncogenic drivers. Cancer Research. 73: 329-329. DOI: 10.1158/1538-7445.Am2013-329 |
0.642 |
|
2013 |
Cheon D, Tong Y, Sim M, Cui X, Berel D, Tighiouart M, Wiedemeyer WR, Karlan B, Orsulic S. Abstract 1511: Stromal gene signature regulated by TGFβ signaling predicts poor clinical outcome in ovarian cancer . Cancer Research. 73: 1511-1511. DOI: 10.1158/1538-7445.Am2013-1511 |
0.72 |
|
2013 |
Aspuria P, Cheon D, Gozo M, Salumbides B, Vergnes L, Asara J, Reue K, Kensicki E, Karlan B, Orsulic S. Abstract 1088: HOXB13 inhibition of succinate dehydrogenase leads to epithelial-to-mesenchymal transition in mouse ovarian cancer cell lines. Cancer Research. 73: 1088-1088. DOI: 10.1158/1538-7445.Am2013-1088 |
0.727 |
|
2013 |
Cheon D, Beach J, Tong Y, Cui X, Tighiouart M, Liu Z, Walts AE, Karlan BY, Orsulic S. Abstract IA11: Using publicly available databases for the functional characterization of cancer genes Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-Ia11 |
0.738 |
|
2013 |
Taylor-Harding B, Agadjanian H, Aspuria PJ, Mizuno T, Cheon D, Orsulic S, Karlan B, Walsh C, Wiedemeyer WR. Abstract B48: Targeting chemo-resistance in CCNE1-amplified ovarian cancer Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B48 |
0.737 |
|
Show low-probability matches. |